glp-1 obesity drug news updates What is the pipeline for future medications for obesity? Weight loss drugs and addiction:

In another cohort study based on 280,090 term infants born at Kaiser Permanente hospitals in northern California between 2011 and 2019, 7,573 (2.7%) infants that had been exposed to SSRIs in late pregnancy, and 11.2% experienced delayed adaptation (defined as a 5-min Apgar score 5, resuscitation at birth, or the administration of respiratory support owing to admission to the neonatal intensive care unit), compared with 4.4% in the unexposed group

Primer on Cerebrovascular Diseases

10.1136/flgastro-2019-101211 14 BlackC

If youre ready to start living your best life, get in touch with us today to schedule your consultation with our medical weight loss team!

10.1073/pnas.86.9.3375 252 ReuleC

doi: 10.3389/fendo.2021.718235